Search by Title Article Topic - Any -AdvocacyCertificationClinical TrialsCoronavirusEarly CareerFellowshipFuture LeadersHeart Failure Awareness 365Heart Failure GuidelinesHFSA Annual Scientific MeetingHFSA AwardsHFSA Board Certification ReviewHFSA CommitteesHFSA Comprehensive Heart Failure ReviewHFSA Learning CenterHFSA MembershipIn The NewsIndustryJournal of Cardiac FailureMentorshipNursingPartnersPatient ResourcePodcastsPresident's UpdatesPress ReleaseProfessional DevelopmentProvider EducationResearchSocial MediaSubmissionsWomen in Heart Failure Article Type - Any -HFSA NewsIndustry NewsPatient NewsPractice News Jan 24 2022 | Eplontersen granted Orphan Drug Designation in the US for transthyretin amyloidosis Industry News Industry Read More Jan 24 2022 | HFSA Releases Review Examining the Growing Economic Burden of Heart Failure in the United States HFSA News Journal of Cardiac Failure Research Read More Jan 23 2022 | HFSA President's Update: January 2022 HFSA News President's Updates Read More Jan 19 2022 | HFSA Women in HF Committee to Host Journal Club January 26 HFSA News HFSA Committees Social Media Women in Heart Failure Read More Jan 10 2022 | CMS Field Testing New Episode-Based Cost Measures January 10-February 25 Practice News Advocacy Read More Pagination Current page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next page Next › Last page Last »
Jan 24 2022 | Eplontersen granted Orphan Drug Designation in the US for transthyretin amyloidosis Industry News Industry Read More
Jan 24 2022 | HFSA Releases Review Examining the Growing Economic Burden of Heart Failure in the United States HFSA News Journal of Cardiac Failure Research Read More
Jan 19 2022 | HFSA Women in HF Committee to Host Journal Club January 26 HFSA News HFSA Committees Social Media Women in Heart Failure Read More
Jan 10 2022 | CMS Field Testing New Episode-Based Cost Measures January 10-February 25 Practice News Advocacy Read More
